For Fragments Based Innovations
 
 
 
 
Products
Rare Organics
Structure Product Information
BIP007
[1,1'-Biphenyl]-2-carbonitrile, 4'-[[1,4'-dimethyl-2'-propyl[2,6'-bi-1H-benzimidazol]-1'-yl]methyl]-
[144702-27-2]
BIP010
[1,1'-Biphenyl]-2-carboxylic acid, 4'-[(1,4'-dimethyl-2'-propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-, methyl ester
[528560-93-2]
BIP011
[1,1'-Biphenyl]-2-carboxylic acid, 2'-[(1,4'-dimethyl-2'-propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-, methyl ester
BIP013
[1,1'-Biphenyl]-2-carboxylic acid, 2'-methyl-
[7111-77-5]
BIP014
[1,1'-Biphenyl]-2-carboxylic acid, 4'-(hydroxymethyl)-
[158144-54-8]
BIP019
[1,1'-Biphenyl]-4-carbonitrile, 2'-methyl-
[189828-30-6]
BIP020
[1,1'-Biphenyl]-4-carbonitrile, 4'-(dibromomethyl)-
[230647-73-1]
BIP021
[1,1'-Biphenyl]-4-carboxylic acid, 4'-(dibromomethyl)-, methylester
BIP022
[1,1'-Biphenyl]-2-carboxylic acid, 4'-[(4'-methyl-2'-propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-
[144701-81-5]
BIP023
[1,1'-Biphenyl]-2-carbonitrile, 4'-[(4'-methyl-2'-propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-
[144702-57-8]
BIP025
[1,1'-Biphenyl]-2-carboxylic acid,4'-[[4-methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzomidazol-1-yl]methyl]-, 1,1-dimethylethyl ester
[144702-26-1]
BIP026
[1,1'-Biphenyl]-2-carbonitrile, 2'-methyl-
[157366-46-6]
BIP028
[1,1'-Biphenyl]-3-carboxylic acid, 2'-methoxy-3'-nitro-
[376591-94-5]
BIP029
[1,1'-Biphenyl]-3-carboxylic acid, 2'-hydroxy-3'-nitro-
[376591-95-6]
BIP030
[1,1'-Biphenyl]-3-carboxylic acid, 3'-amino-2'-hydroxy-
[376592-93-7]
BIP032
[2,2'-Bipyrimidine]-4,6(1H,5H)-dione, 5-(2-methoxyphenoxy)-
[150728-12-4]
BIP033
2,2'-Bipyrimidine, 4,6-dichloro-5-(2-methoxyphenoxy)-
[150728-13-5]
BIP035
10H-3,10'-biphenothiazine,2,2'-bis(ethylthio)-10-[3-(4-methylpiperazin-1-yl)propyl]-
BIP036
[1,1'-Biphenyl]-2-carboxylic acid, 4'-[(1,7'-dimethyl-2'-propyl[2,5'-bi-1H-benzimidazol]-1'-yl)methyl]-
[1026353-20-7]
BIP037
[1,1'-Biphenyl]-2-carboxylic acid, 4'-(bromomethyl)-
[150766-86-2]
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement and its liability is at buyer's risk. 
Page [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120]

 


New products

Copyright © 2010-2015 Fragmenta. All rights reserved.  Terms of Use | Order and Payment Terms | Help